Revvity Inc (RVTY)

Apr 24, 2025, 4:05 PM EDT - 2 days ago

Revvity Board Declares Quarterly Dividend

Apr 23, 2025, 8:00 AM EDT - 3 days ago

Watchmaker Genomics and Revvity Team to Automate and Streamline NGS Library Preparation

Apr 22, 2025, 8:00 AM EDT - 4 days ago

Revvity Fuels the Future of Cancer Science with New Research Solutions

RSSS

Apr 3, 2025, 8:00 AM EDT - 23 days ago

Revvity to Hold Earnings Call on Monday, April 28, 2025

Apr 2, 2025, 8:00 AM EDT - 24 days ago

Revvity Signals Software Unveils Unified Data Platform to Accelerate Drug Discovery

Apr 2, 2025, 8:00 AM EDT - 24 days ago

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

Mar 20, 2025, 1:00 PM EDT - 5 weeks ago

Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England

Mar 11, 2025, 12:00 PM EDT - 6 weeks ago

PerkinElmer Acquires Project Farma, Expanding Its OneSource Professional Services Offering for the Life Sciences Industry

Mar 3, 2025, 8:00 AM EST - 7 weeks ago

Revvity's EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Feb 20, 2025, 12:30 PM EST - 2 months ago

Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group

Feb 20, 2025, 8:00 AM EST - 2 months ago

Revvity to Present at Upcoming Investor Conferences

Jan 31, 2025, 9:34 AM EST - 3 months ago

Revvity, Inc. (RVTY) Q4 2024 Earnings Call Transcript

Jan 31, 2025, 7:32 AM EST - 3 months ago

Revvity forecasts 2025 revenue, profit below estimates amid weak biotech spending

Jan 31, 2025, 6:00 AM EST - 3 months ago

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024

Jan 23, 2025, 8:00 AM EST - 3 months ago

Revvity Ignites Scientific Breakthroughs at SLAS2025

Jan 13, 2025, 8:00 AM EST - 3 months ago

Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing

Jan 12, 2025, 5:00 PM EST - 3 months ago

Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance

Jan 10, 2025, 8:00 AM EST - 3 months ago

Revvity Announces FDA Clearance for First Automated Free Testosterone Test

Dec 17, 2024, 8:00 AM EST - 4 months ago

Revvity to Present at J.P. Morgan Healthcare Conference

Dec 16, 2024, 12:27 AM EST - 4 months ago

Safe Biopharma: Revvity's Recurring Revenues And Diagnostics

Dec 13, 2024, 1:57 PM EST - 4 months ago

Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst

DHR

Nov 20, 2024, 8:00 AM EST - 5 months ago

Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK

Nov 19, 2024, 8:00 AM EST - 5 months ago

Scale Biosciences and Revvity's BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells

Nov 19, 2024, 8:00 AM EST - 5 months ago

Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference

Nov 18, 2024, 8:00 AM EST - 5 months ago

Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation

Nov 5, 2024, 2:06 PM EST - 6 months ago

These Analysts Revise Their Forecasts On Revvity Following Q3 Results

Nov 4, 2024, 12:30 PM EST - 6 months ago

Revitty (RVTY) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 7:55 AM EST - 6 months ago

Revvity cuts 2024 revenue forecast amid biotech spending slowdown

Nov 4, 2024, 6:00 AM EST - 6 months ago

Revvity Announces Financial Results for the Third Quarter of 2024

Oct 22, 2024, 9:00 AM EDT - 6 months ago

Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories

Oct 22, 2024, 8:00 AM EDT - 6 months ago

Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report

Oct 7, 2024, 8:00 AM EDT - 7 months ago

Revvity To Hold Earnings Call on Monday, November 4, 2024

Oct 2, 2024, 8:00 AM EDT - 7 months ago

Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE Gene

Jul 29, 2024, 11:25 AM EDT - 9 months ago

Diagnostic Products Demand Boosts Profit and Sales at Revvity

Jul 29, 2024, 11:23 AM EDT - 9 months ago

Revvity, Inc. (RVTY) Q2 2024 Earnings Call Transcript

Jul 29, 2024, 8:11 AM EDT - 9 months ago

Revvity raises 2024 profit forecast on medical equipment demand; shares rise

Jul 29, 2024, 6:00 AM EDT - 9 months ago

Revvity Announces Financial Results for the Second Quarter of 2024

Jul 9, 2024, 8:00 AM EDT - 10 months ago

Revvity To Hold Earnings Call on Monday, July 29, 2024

May 28, 2024, 8:00 AM EDT - 11 months ago

Revvity to Present at Goldman Sachs Global Healthcare Conference

May 23, 2024, 9:17 AM EDT - 1 year ago

Lab Instrument Industry Update - New Commercial Entrants

AKYA BNGO CTKB DHR LAB MASS OMIC

Apr 29, 2024, 11:28 AM EDT - 1 year ago

Revvity, Inc. (RVTY) Q1 2024 Earnings Call Transcript

Apr 29, 2024, 7:42 AM EDT - 1 year ago

Revvity beats quarterly estimates on demand for diagnostic equipment

Apr 29, 2024, 6:00 AM EDT - 1 year ago

Revvity Announces Financial Results for the First Quarter of 2024

Apr 25, 2024, 8:00 AM EDT - 1 year ago

Revvity to Present at BofA Securities 2024 Health Care Conference

Apr 24, 2024, 6:00 AM EDT - 1 year ago

Revvity Unveils a New Era of Automated Tuberculosis Testing

Apr 15, 2024, 6:00 AM EDT - 1 year ago

Revvity Signals Software's New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners

Apr 4, 2024, 8:00 AM EDT - 1 year ago

Revvity To Hold Earnings Call on Monday, April 29, 2024

Apr 2, 2024, 6:00 AM EDT - 1 year ago

Preliminary Injunction Granted to Enforce Revvity's Rights and Cloud Software Group's Obligations Related to Spotfire Software

Mar 21, 2024, 11:27 AM EDT - 1 year ago

Revvity: Enter Now As Reorganization Takes Shape

Mar 20, 2024, 5:00 PM EDT - 1 year ago

Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group